Literature DB >> 34786786

Identifying dementia in Down syndrome with the Severe Impairment Battery, Brief Praxis Test and Dementia Scale for People with Learning Disabilities.

E R Wallace1, J P Harp2, K L Van Pelt3, L M Koehl2, A M Caban-Holt3, A J Anderson-Mooney2, G A Jicha2,3, D D Lightner2, W C Robertson2, E Head4, F A Schmitt2,3.   

Abstract

BACKGROUND: Individuals with Down syndrome (DS) are at high risk for dementia, specifically Alzheimer's disease. However, many measures regularly used for the detection of dementia in the general population are not suitable for individuals with DS due in part to floor effects. Some measures, including the Severe Impairment Battery (SIB), Brief Praxis Test (BPT) and Dementia Scale for People with Learning Disabilities (DLD), have been used in clinical trials and other research with this population. Validity research is limited, particularly regarding the use of such tools for detection of prodromal dementia in the DS population. The current project presents baseline cross-sectional SIB, BPT and DLD performance in order to characterise their predictive utility in discriminating normal cognition, possible dementia and probable dementia in adult DS.
METHOD: Baseline SIB, BPT and DLD performances from 100 individuals (no dementia = 68, possible dementia = 16 & probable dementia = 16) were examined from a longitudinal cohort of aging individuals with DS. Receiver operating characteristic curves investigated the accuracy of these measures in relation to consensus dementia diagnoses, diagnoses which demonstrated high percent agreement with the examining neurologist's independent diagnostic impression.
RESULTS: The SIB and BPT exhibited fair discrimination ability for differentiating no/possible versus probable dementia [area under the curve (AUC) = 0.61 and 0.66, respectively]. The DLD exhibited good discrimination ability for differentiating no versus possible/probable dementia (AUC = 0.75) and further demonstrated better performance of the DLD Cognitive subscale compared with the DLD Social subscale (AUC = 0.77 and 0.67, respectively).
CONCLUSIONS: Results suggest that the SIB, BPT and DLD are able to reasonably discriminate consensus dementia diagnoses in individuals with DS, supporting their continued use in the clinical assessment of dementia in DS. The general performance of these measures suggests that further work in the area of test development is needed to improve on the AUCs for dementia status discrimination in this unique population. At present, however, the current findings suggest that the DLD may be the best option for reliable identification of prodromal dementia in this population, reinforcing the importance of including informant behaviour ratings in assessment of cognition for adults with DS.
© 2021 MENCAP and International Association of the Scientific Study of Intellectual and Developmental Disabilities and John Wiley & Sons Ltd.

Entities:  

Keywords:  Down syndrome; cognition; dementia

Mesh:

Year:  2021        PMID: 34786786      PMCID: PMC8842513          DOI: 10.1111/jir.12901

Source DB:  PubMed          Journal:  J Intellect Disabil Res        ISSN: 0964-2633


  38 in total

1.  Current estimate of Down Syndrome population prevalence in the United States.

Authors:  Angela P Presson; Ginger Partyka; Kristin M Jensen; Owen J Devine; Sonja A Rasmussen; Linda L McCabe; Edward R B McCabe
Journal:  J Pediatr       Date:  2013-07-23       Impact factor: 4.406

2.  Vitamin E in aging persons with Down syndrome: A randomized, placebo-controlled clinical trial.

Authors:  Mary Sano; Paul S Aisen; Howard F Andrews; Wei-Yann Tsai; Florence Lai; Arthur J Dalton
Journal:  Neurology       Date:  2016-05-04       Impact factor: 9.910

3.  The 'Severe Impairment Battery': assessing cognitive ability in adults with Down syndrome.

Authors:  P Witts; S Elders
Journal:  Br J Clin Psychol       Date:  1998-05

4.  Prospective study of the prevalence of Alzheimer-type dementia in institutionalized individuals with Down syndrome.

Authors:  F E Visser; A P Aldenkamp; A C van Huffelen; M Kuilman; J Overweg; J van Wijk
Journal:  Am J Ment Retard       Date:  1997-01

5.  Rapid assessment of cognitive function in down syndrome across intellectual level and dementia status.

Authors:  D M Walsh; E Doran; W Silverman; A Tournay; N Movsesyan; I T Lott
Journal:  J Intellect Disabil Res       Date:  2015-05-29

6.  A short form of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): development and cross-validation.

Authors:  A F Jorm
Journal:  Psychol Med       Date:  1994-02       Impact factor: 7.723

7.  A prospective 14-year longitudinal follow-up of dementia in persons with Down syndrome.

Authors:  M McCarron; P McCallion; E Reilly; N Mulryan
Journal:  J Intellect Disabil Res       Date:  2013-07-31

Review 8.  Aging in Down Syndrome and the Development of Alzheimer's Disease Neuropathology.

Authors:  Elizabeth Head; Ira T Lott; Donna M Wilcock; Cynthia A Lemere
Journal:  Curr Alzheimer Res       Date:  2016       Impact factor: 3.498

9.  Maladaptive behaviors related to dementia status in adults with Down syndrome.

Authors:  Tiina K Urv; Warren B Zigman; Wayne Silverman
Journal:  Am J Ment Retard       Date:  2008-03

10.  Frontal-subcortical behaviors during Alzheimer's disease in individuals with Down syndrome.

Authors:  Luciana Mascarenhas Fonseca; Guilherme Prado Mattar; Glenda Guerra Haddad; Aline Souza Gonçalves; André de Queiroz Constantino Miguel; Laura Maria Guilhoto; Shahid Zaman; Anthony J Holland; Cassio Machado de Campos Bottino; Marcelo Queiroz Hoexter
Journal:  Neurobiol Aging       Date:  2019-03-11       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.